Products Management Services - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe Introduction - EU Implemen

July 28, 2022

The Europe Introduction - EU Implementation Guide has been prepared by the European Medicines Agency (EMA) upon consultation with different stakeholders (representatives of marketing authorisation holders and sponsors, national competent authorities, industry associations, international public organisations and software vendors) through the SPOR Task Force (SPOR TF) and the EU Telematics governance.

The International Organisation for Standardisation (ISO) Identification of Medicinal Products (IDMP) standards specify the use of standardised definitions for the identification and description of medicinal products for human use. The purpose of these standards is to facilitate the reliable exchange of medicinal product information in a robust and consistent manner, by providing a common product ’language’ for stakeholders to use in their interactions.

The use of ISO IDMP standards is required in accordance with Articles 25 and 26 of Commission Implementing Regulation (EU) No 520/2012. These provisions mandate member states (MSs), marketing authorisation holders (MAHs) and the European Medicines Agency (EMA) to use ISO IDMP standards for the exchange and communication of information on medicinal products.

To pursue the implementation of the ISO IDMP standards, EMA has established services to support the management of master data including:

These services are together referred to as 'SPOR' throughout this guidance (Substance, Product, Organisation and Referentials Management Services).

Within the context of Product Management Service (PMS), implementation of the ISO IDMP standards is governed by the following specifications:

  • ISO IDMP Implementation Guides (Technical Specifications): define the technical details on how to implement the standards, such as specific fields, their formats, and business rules describing their use;
  • HL7 messaging specifications: define the messages that will be used to exchange IDMP information, which are based on HL7 (Health Level Seven) standards; EU Implementation Guide (EU IG): provides guidance on the interpretation of data fields specifically for the EU regulatory environment as well as guidance on the processes for submitting and updating data.

 

Download EU Implementation Guide

Download Chapter 2

Download Chapter 8 (Practical Examples)

Download Chapter 8 Annex I: Complete representation

 

Interested in learning more? Contact us today to find out how we can help with your global regulatory needs.




pesticides Europe

July 28, 2022

Draft report on the development of a harmonised approach to exposure assessment methodologies for residues from veterinary medicinal products, feed additives and pesticides in food of animal origin

In 2020, the European Commission (EC) requested EMA and European Food Safety Authority (EFSA) for advice for the development of a harmonised approach on exposure assessment methodologies for residues...

Read More
EMA Europe

July 28, 2022

Advice on the designation of antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans - in relation to implementing measures under Article 37(5) of Regulation

Regulatory and Procedural Guideline May 2022 EMA/CVMP/678496/2021-rev Introduction “According to Article 37(5) of Regulation (EU) 2019/6 (‘the Regulation’), the European Commission shall adopt...

Read More
General Regulatory Regulatory Sciences

July 28, 2022

#2: Labeling for Human Prescription Drug and Biological Products – Implementing the PLR Content and Format Requirements

In 2013, the FDA released a guidance entitled “Labeling for Human Prescription Drug and Biological Products – Implementing the PLR Content and Format Requirements.”  This guidance was finalized after...

Read More